Dr. Kent Kester
Board Member
Turn Therapeutics Inc. (TTRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Turn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get TTRX alertsAbout Dr. Kent Kester
Dr. Kent Kester is recorded as Board Member at Turn Therapeutics Inc. (TTRX) since September 30, 2025. The newest filing on record that lists Dr. Kent Kester as Board Member at Turn Therapeutics Inc. (TTRX) is dated October 19, 2026. Turn Therapeutics Inc. reported in an 8-K filed October 2, 2025 that Dr. Kent Kester was appointed director, effective September 30, 2025. Turn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Turn Therapeutics Inc. includes Bradley Burnam (CEO and Board Member), Zuraiz Chaudhary (CFO), Andrew Gengos (Board Member) and 3 others.
“On September 30, 2025, in connection with the Direct Listing and immediately after the Effective Time, Arthur Golden and Dr. Kent Kester were appointed to the board of directors of the Company (the "Board").”
Affiliation history
-
Current
2025-09-30–present
Last confirmed October 19, 2026
Company network
Leadership on record at Turn Therapeutics Inc.
- Bradley Burnam CEO, Board Member
- Zuraiz Chaudhary CFO
- Andrew Gengos Board Member
- Arthur Golden Board Member
- Dr. Neil Ghodadra Board Member
- Martin Dewhurst Board Member